5000
Oxaloacetic Acid - CAS 328-42-7 - Calbiochem
Substrate for malate dehydrogenase and oxaloacetate decarboxylase.
Synonym(s):
Oxaloacetic Acid - CAS 328-42-7 - Calbiochem, OAA
Sign Into View Organizational & Contract Pricing
About This Item
Empirical Formula (Hill Notation):
C4H4O5
CAS Number:
Molecular Weight:
132.07
MDL number:
UNSPSC Code:
12352200
Quality Level
Assay
>98% (titration)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
color
white to off-white
solubility
water: soluble
shipped in
ambient
storage temp.
2-8°C
InChI
1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9)
InChI key
KHPXUQMNIQBQEV-UHFFFAOYSA-N
General description
Substrate for malate dehydrogenase and oxaloacetate decarboxylase.
Preparation Note
Following reconstitution, refrigerate (4°C).
Other Notes
Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
Flint, D.H. 1993. Biochemistry 32, 799.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Corrosive (L)
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2
Storage Class Code
13 - Non Combustible Solids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Takeshi Yoshida et al.
Frontiers in cell and developmental biology, 7, 316-316 (2019-12-19)
Infantile-onset Pompe disease (IOPD) is a life-threatening multi-organ disease caused by an inborn defect of lysosomal acid α-glucosidase (GAA), which can degrade glycogen into glucose. Lack of GAA causes abnormal accumulation of glycogen in the lysosomes, particularly in the skeletal
Hiroyuki Kabayama et al.
Nature communications, 11(1), 336-336 (2020-01-19)
Targeting cytoplasmic protein-protein interactions with antibodies remains technically challenging, since antibodies expressed in the cytosol frequently form insoluble aggregates. Existing engineering methods are based on the notion that the estimated net charge at pH 7.4 affects stability; as such, they
Ryoki Nakamura et al.
Communications biology, 3(1), 240-240 (2020-05-18)
Members of the leucine-rich repeat-containing 8 (LRRC8) protein family, composed of the five LRRC8A-E isoforms, are pore-forming components of the volume-regulated anion channel (VRAC). LRRC8A and at least one of the other LRRC8 isoforms assemble into heteromers to generate VRAC
Nabila Haji et al.
Molecular autism, 11(1), 29-29 (2020-05-08)
Mutations in TSC1 or TSC2 genes cause tuberous sclerosis complex (TSC), a disorder associated with epilepsy, autism, and intellectual disability. TSC1 and TSC2 are repressors of the mechanistic target of rapamycin complex 1 (mTORC1), a key regulator of protein synthesis.
Sara Merlo et al.
Biomolecules, 10(3) (2020-03-04)
Melatonin exerts direct neuroprotection against cerebral hypoxic damage, but the mechanisms of its action on microglia have been less characterized. Using both in vitro and in vivo models of hypoxia, we here focused on the role played by silent mating
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service